Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M105150200 on September 27, 2001

J. Biol. Chem., Vol. 276, Issue 50, 46770-46778, December 14, 2001
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/50/46770    most recent
M105150200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimada, N.
Right arrow Articles by Watanabe, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimada, N.
Right arrow Articles by Watanabe, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Dual Mode Recognition of Two Isoacceptor tRNAs by Mammalian Mitochondrial Seryl-tRNA Synthetase*

Nobukazu ShimadaDagger , Tsutomu SuzukiDagger §, and Kimitsuna WatanabeDagger §

From the Dagger  Department of Chemistry and Biotechnology, Graduate School of Engineering, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8656 and the § Department of Integrated Biosciences, Graduate School of Frontier Sciences, University of Tokyo, 5-1-5 Kashiwanoha, Kashiwa, Chiba 277-8583, Japan

Received for publication, June 5, 2001, and in revised form, September 21, 2001


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Animal mitochondrial translation systems contain two serine tRNAs, corresponding to the codons AGY (Y = U and C) and UCN (N = U, C, A, and G), each possessing an unusual secondary structure; tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (for AGY) lacks the entire D arm, whereas tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (for UCN) has an unusual cloverleaf configuration. We previously demonstrated that a single bovine mitochondrial seryl-tRNA synthetase (mt SerRS) recognizes these topologically distinct isoacceptors having no common sequence or structure. Recombinant mt SerRS clearly footprinted at the TPsi C loop of each isoacceptor, and kinetic studies revealed that mt SerRS specifically recognized the TPsi C loop sequence in each isoacceptor. However, in the case of tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, TPsi C loop-D loop interaction was further required for recognition, suggesting that mt SerRS recognizes the two substrates by distinct mechanisms. mt SerRS could slightly but significantly misacylate mitochondrial tRNAGln, which has the same TPsi C loop sequence as tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, implying that the fidelity of mitochondrial translation is maintained by kinetic discrimination of tRNAs in the network of aminoacyl-tRNA synthetases.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The fidelity of protein synthesis relies on the specific attachment of amino acids to their cognate tRNA species. This process is catalyzed by aminoacyl-tRNA synthetase (ARS),1 each species of which discriminates with high selectivity among the many structurally similar tRNAs and amino acids (1, 2). To avoid misacylation of tRNAs from any of the 19 non-cognate groups, tRNAs possess identity elements within their sequence or tertiary structure that are strictly recognized only by the cognate synthetase. These identity elements are most commonly located in the anticodon and in the acceptor stem, particularly the discriminator base at position 73 (2, 3). However, in the case of the serine tRNA of Escherichia coli, several biochemical experiments have revealed that neither the anticodon stem/loop nor the discriminator base is involved in recognition (4, 5); instead, the E. coli tRNASer identity elements are located in the characteristic long extra arm (4-7). These findings conform well with analyses of the crystallographic structures of seryl-tRNA synthetase (SerRS)-tRNASer complexes from E. coli and Thermus thermophilus (8-10), which indicate that the N-terminal long helical domain of SerRS plays an important role in recognizing the long extra arm and the TPsi C loop of tRNASer. In eukaryotic systems, cytoplasmic tRNASer also has a long variable arm, and biochemical studies of Saccharomyces cerevisiae and human tRNAsSer have revealed that it contains the major identity element of tRNASer (11-14). The recognition mechanism of SerRS thus appears to be evolutionarily conserved in both prokaryote and eukaryotic cytoplasm.

The mammalian mitochondrial (mt) translation system utilizes two tRNASer species, one specific for codon AGY and the other for UCN. Neither of these tRNAs has a long extra arm as a recognition site for cytoplasmic SerRS (15). In addition, each possesses an unusual secondary structure; tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (for codon AGY) lacks the entire D arm (16), whereas tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (for codon UCN) has an unusual cloverleaf configuration with an extended anticodon stem (17). We previously demonstrated that the single mt SerRS recognizes these distinct isoacceptors with almost the same activity (18). Additionally, inspection of the primary sequences of several mt SerRSs revealed differences between mammalian mt SerRS and its prokaryotic counterpart in the N-terminal domain responsible for tRNA recognition, which are in line with structural and recognition differences between the extra arms of mammalian mt and prokaryotic tRNAsSer. Because no other tRNA investigated to date recognizes structurally different tRNA isoacceptors, it is supposed that the recognition mechanism of mammalian mt SerRS differs considerably from that of any other ARS.

Elucidating the mystery of how mammalian mt SerRS recognizes and discriminates two isoacceptors with no common structure and sequence from non-cognate tRNAs will not only extend our knowledge of the recognition mechanism of ARS but also shed light on hidden aspects of the mammalian mt translation system.

To investigate the recognition mechanism of mammalian mt SerRS, we recombinantly expressed bovine mt SerRS in E. coli and performed a series of biochemical experiments using this enzyme and several tRNA variants. On the basis of the results, we report here the unique recognition mechanism of mammalian mt SerRS.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Materials-- Phenylmethanesulfonyl fluoride was purchased from Sigma; [14C]L-serine (5.59 GBq/mmol), [32P]pCp, and a HiTrap chelating column were from Amersham Pharmacia Biotech; the vector pET-19b was from Novagen; nucleotide-specific RNases T1 and U2 were from Amersham Pharmacia Biotech and Seikagaku Kogyo (Tokyo), respectively; vectors pUC18 and pUC19 were from Takara; an anion-exchange tip was from Qiagen; and a QuikChangeTM site-directed mutagenesis kit was from Stratagene. Recombinant mt LeuRS was overproduced from an expression vector kindly provided by Dr. L. L. Spremulli (University of North Carolina, Chapel Hill, NC). Native bovine mt tRNAs were purified from bovine mitochondria by selective hybridization using a solid phase DNA probe as described by Wakita et al. (19).

Construction of Expression Plasmid-- cDNA for bovine mt SerRS without an N-terminal peptide for mitochondrial importation was amplified by PCR using synthetic primers; a forward primer corresponding to the N-terminal end of mature mt SerRS (atataccatgggccatcatcatcatcatcatcatggcagcgacgacgacgacaaggcaacggagaggcaggatcg) possessing an NcoI site, and a reverse primer for the C-terminal end (cagccggatcctcagctcgaggcaggctgg) carrying a BamHI site. The PCR product was cloned into pET-19b to construct an expression vector for mature bovine mt SerRS with a hexahistidine tag in the N-terminal region.

Expression and Purification of mt SerRS-- E. coli BL21 (DE3) was used as a host for expression of the recombinant mt SerRS. The culture conditions for overproducing cells were optimized to maximum the expression of soluble enzyme. The transformant was cultured in LB broth (100 µg/ml ampicillin) at 37 °C to an A600 value of 0.6, and then induced by 10 µM isopropyl-1-thio-beta -D-galactopyranoside for 20 h at 28 °C. Cells harvested from 3 liters of LB broth were resuspended in 40 ml of HT buffer (50 mM Hepes-KOH (pH 7.6), 100 mM KCl, 10 mM MgCl2, and 7 mM beta -mercaptoethanol) containing 0.2 mM phenylmethanesulfonyl fluoride, 0.03% (w/v) egg white lysozyme, and 0.1% Triton X-100 and disrupted by 12-min sonication (repeated 1-s bursts after 4-s cooling periods) at 100 watts and 0 °C. The homogenate was cleared by centrifugation at 100,000 × g for 60 min. The supernatant fraction (S100) was loaded onto a nickel-charged HiTrap chelating column (5 ml). After washing out nonbound proteins, the recombinant protein was eluted with a 60-ml linear gradient from 0 to 350 mM imidazole in HT buffer. mt SerRS was eluted in a fraction containing ~200 mM imidazole. Protein concentrations were determined with a Bio-Rad protein assay kit using bovine serum albumin as a standard. Glycerol was added to pooled mt SerRS fractions at a final concentration of 30%, frozen quickly with liquid nitrogen, and stored at -70 °C.

Native PAGE and Gel Retardation Assay-- The mt tRNASer-mt SerRS complex was formed as described by Yokogawa et al. (18). Native PAGE was performed as described by Hornung et al. (20); the gel was stained with Coomassie Brilliant Blue and toluidine blue to analyze the components of the mt tRNASer-mt SerRS complex. To determine the Kd value by gel retardation assay, each mt tRNASer was labeled with 32P at the 5' end. Nonradioactive mt tRNASer was added to each labeled tRNA as a carrier tRNA. Assays were performed by using five different concentrations of tRNAsSer ranging from 0.25 to 5 µM (0.25, 1.0, 3, 4, and 5 µM) for tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> or from 0.25 to 3 µM (0.25, 0.5, 1.0, 2.0, and 3.0 µM) for tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> with a fixed concentration (0.44 µM) of mt SerRS. The relative radioactivity of the RNA band was quantified by a BAS-1000 imaging system (Fuji Photo Film). The amounts of tRNASer-mt SerRS complexes were calculated by subtracting the free tRNA counts from that of the whole count. The Kd value for each native tRNASer was obtained by Scatchard plots.

tRNA Footprinting with Ethylnitrosourea-- tRNA footprinting using ethylnitrosourea was performed as described by Vlassov et al. (21) with slight modification. mt tRNASer was alkylated with or without mt SerRS at room temperature for 4 h in a reaction mixture containing 5' end-labeled mt tRNASer (~50,000 cpm/tube) with 1.5 µM cold carrier tRNASer, 50 mM sodium cacodylate (pH 8.0), 10 mM MgCl2, and 0.11 volume of saturated ethylnitrosourea (ethanol solution). The recombinant mt SerRS and non-cognate mt LeuRS were added to the reaction mixture at final concentrations of 1-5 and 5 µM, respectively. The following experiment conducted after the alkylation was described previously (21). Electrophoresis using 12% acrylamide, 7 M urea gel was performed to analyze the footprint site of tRNASer in the presence of mt SerRS. The band position was assigned by comparison with partial RNase T1 and/or U2 digests. The gel was exposed to an imaging plate, followed by analysis using a Fuji BAS-1000 imaging analyzer.

Preparation of in Vitro Transcribed tRNAs-- Mitochondrial tRNA variant genes were constructed on pUC18 under a T7 class III promoter as described previously (22). The transcriptional template harboring the T7 promoter and tRNA gene terminating at its discriminator base (position 73) was amplified from the constructed plasmid by PCR and transcribed to in vitro according to the literature (23), except that the reaction mixture contained E. coli CCA, adding at 8 µg/1 ml. After the reaction, a small part of the mixture was electrophoresed on 12% long denaturing polyacrylamide gel (40 cm × 20 cm × 0.35 mm) to check the purity of the synthesized tRNA. All tRNA variants with the complete CCA sequence at the 3' end were synthesized with more than 70% purity. The transcribed tRNA was extracted by phenol/chloroform treatment, applied onto an anion-exchange tip (Qiagen), and then the complete tRNA band was cut out from the 12% denaturing gel to separate it from the adjacent minor bands. In this way, highly purified tRNA was obtained. The 3' end of each tRNA was confirmed by thin layer chromatography analysis of the 3'-terminal adenosine, which was labeled with [32P]pCp (data not shown). In addition, the RNA sequences of some variants were verified by Donis-Keller's enzymatic digestion method (data not shown) (24). We finally succeeded in recovering about 0.2 A260 unit of pure tRNA/1-ml reaction mixture.

Preparation of tRNA Variants by in Vivo Expression-- To prepare variants of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> in vivo, the plasmid vector pUC19 carrying the tRNA gene with the T7 promoter and terminator was constructed as reported previously (25). The plasmids for the other tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> derivatives used were prepared with a QuikChangeTM site-directed mutagenesis kit (Stratagene). tRNA variants were expressed in E. coli strain BL21 (DE3) according to Hayashi et al. (25). Expressed tRNA was extracted from the cells as described (26) and purified by electrophoresis on 8% polyacrylamide gel containing M urea and 20% formamide.

Aminoacylation Assay-- The aminoacylation reaction was performed as described by Yokogawa et al. (18). The initial rates of aminoacylation were ascertained by using six different tRNA concentrations between 0.1 and 2 µM, determined, respectively, according to the amount of each tRNA recovered. In each case, mt SerRS was used at a fixed concentration optimized according to the activity of each tRNA and ranging from 7.15 nM to 14.3 µM. Kinetic experiments gave reasonable Hanes-Woolf plots for determining the kinetic parameters of Km and kcat. All values are the averages of three independent determinations, which varied less than 15%. The aminoacylation reaction for the minihelix tRNAsSer and non-cognate mt tRNAs for Gln, Glu, and Tyr was carried out in 60 µl of a reaction mixture containing 18 pmol of tRNA substrate and 9.5 µg of mt SerRS. At each point, a 10-µl aliquot was withdrawn. We calculated the quantity of each tRNA per A260 unit according to its length, namely 1800 pmol for tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> and its variants, 2000 pmol for tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> and 3600 pmol for the two minihelix tRNAs. Other conditions were the same as those used to determine the kinetic parameters.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Characterization of Recombinant mt SerRS-- Because it is almost impossible to obtain sufficient native mt SerRS from bovine liver to carry out a detailed investigation of the recognition mechanism, recombinant mt SerRS with an N-terminal histidine tag was overexpressed in E. coli cells. The optimized culture conditions for maximum expression of the soluble protein are described under "Experimental Procedures." As shown in Fig. 1, mt SerRS was purified almost homogeneously by nickel-chelating chromatography. The yield was 8.4 mg from 1 liter of the cell culture.


View larger version (69K):
[in this window]
[in a new window]
 
Fig. 1.   SDS-PAGE analysis of purified bovine recombinant mt SerRS. Lane 1, molecular weight markers with their sizes indicated in kDa; lanes 2 and 3, whole-cell extract and its soluble fraction from BL21 (DE3) carrying pET-19b-mt SerRS after induction, respectively; lane 4, 1.7 µg of mt SerRS purified by nickel affinity chromatography. The gel concentration was 9%, and the proteins were visualized by Coomassie Brilliant Blue staining.

The overall structure of the recombinant mt SerRS was examined by measuring the circular dichroism (CD) in the far-UV spectrum, which exhibited CD troughs at 209 and 222 nm, typically indicative of a high alpha -helical content (data not shown). E. coli SerRS has a similar CD spectrum. According to the online COILS algorithm for the prediction of coiled coils from amino acid sequences (dot.imgen.bcm.tmc.edu:9331/seq-search/struc-predict.html) (29), mt SerRS has a single long alpha -helix in the N-terminal region (residues 57-87), which could explain the CD spectral observation that mt SerRS has a high helical content similar to that of E. coli SerRS. In the crystal structure, E. coli SerRS is known to have two long anti-parallel alpha -helices in the N-terminal domain (residues 28-53 and 71-103) (27, 28), which were clearly predicted by the COILS algorithm.

In addition, the apparent molecular mass of mt SerRS in solution was estimated by gel filtration column chromatography. The enzyme was eluted mainly at 33 min, corresponding to a molecular mass of 109 kDa, with minor peak at 37 min corresponding to 57 kDa (data not shown). As the molecular mass of the enzyme has been calculated from its gene sequence to be 56.3 kDa (18), mammalian mt SerRS seems to take a homodimeric form, as is the case with prokaryotic SerRS (9, 27, 28, 30).

To establish whether the recombinant mt SerRS could specifically recognize the two mt tRNAsSer, the serylation activity kinetic parameters were determined using the native mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> and tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> as substrates. As shown in Table I, the parameters of the recombinant mt SerRS were almost identical to those of the native mt SerRS. A gel retardation assay was performed to ascertain the complex formation of mt SerRS with each isoacceptor. The assay showed that mt SerRS specifically formed binary complexes with the two serine isoacceptors, whereas no complex was formed with non-cognate mt tRNA<UP><SUB>UAA</SUB><SUP>Leu</SUP></UP> (Fig. 2A). The dissociation constant (Kd) for each tRNA substrate was determined by means of Scatchard plots (Fig. 2B). The larger Kd value of tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (1 µM) is indicative of a lower affinity toward mt SerRS. The difference in the dissociation constants seems to reflect the different Km values of the two substrates (Table I). In addition, it appears that the x-intercept of each Scatchard plot approaches 1.8, suggesting that the two tRNAsSer bind into one dimeric form of mt SerRS, although further structural analysis is necessary to clarify the stoichiometry of the mt SerRS-tRNASer complex.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Kinetic parameters in aminoacylation of bovine mitochondrial serine tRNAs
Experimental conditions for aminoacylation are described under "Experimental Procedures."


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 2.   Native PAGE analysis of complex formation between bovine mt tRNAsSer and mt SerRS. A, native PAGE analysis showing that mt SerRS formed a stable complex with both mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> and mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>. Lane 1, mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (0.02 A260 unit); lane 2, mt SerRS (0.1 µg); lane 3, mt SerRS and 0.01 A260 unit of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP>; lane 4, mt SerRS and 0.01 A260 unit of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>; lane 5, mt SerRS and 0.01 A260 unit of mt tRNA<UP><SUB>UAA</SUB><SUP>Leu</SUP></UP>. Lane 1 and lanes 2-5 are separated because irrelevant lanes are omitted, but the stains originate from the same gel. The gel was stained with Coomassie Brilliant Blue and toluidine blue. B, Scatchard plots of the complex band to determine the Kd value for each mt tRNASer complexed with mt SerRS. Complex formation was monitored with varying concentrations of mt tRNASer (see "Experimental Procedures"). The Kd value for each mt tRNASer determined by the plot is displayed in each graph. The values n and f represent the number of mt tRNASer molecules binding to one dimer of mt SerRS and the concentration of free mt tRNASer, respectively.

Because the foregoing observations strongly suggested that the recombinant mt SerRS retained the original characteristics of the native enzyme, the subsequent experiments were performed with this recombinant enzyme.

mt SerRS Contact Sites on the Two Serine tRNAs-- tRNA footprinting was carried out with ethylnitrosourea for both mt tRNAsSer in the presence of mt SerRS, which strongly protected mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> against alkylation by ethylnitrosourea at two specific regions, i.e. phosphate positions 57-58 and 64-67 (Fig. 3A). mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> was also protected at similar phosphate positions (55-59 and 65-67). No protection was observed in the presence of human mt leucyl-tRNA synthetase (mt LeuRS), which was used as a negative control for each mt tRNA (lanes 5 and 6 in Fig. 3, A and B, respectively). Moreover, no strong protection was found in the 5' region of mt tRNAsSer (data not shown). These results indicate that the probable contact sites on both tRNAs are on the TPsi C loop and at the bottom of the acceptor stem. As shown in Fig. 3C, mammalian mt SerRS contacts both tRNAs at similar positions though they have different topologies.


View larger version (54K):
[in this window]
[in a new window]
 
Fig. 3.   Identification of footprinted sites on both isoacceptors by mt SerRS using ethylnitrosourea. A, footprinting of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP>. Lanes 1 and 2, control experiments in the absence of reagent and enzyme, and in the absence of reagent only, respectively; lane 3, alkylation in the absence of enzyme; lanes 4 and 5, alkylation in the presence of mt SerRS (5 µM) and human mt LeuRS (5 µM), respectively; lane 6, partial ribonuclease T1 digest to assign the ladders. B, footprinting of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>. Lane 1, control incubation in the absence of reagent and enzyme; lane 2, alkylation in the absence of enzyme; lanes 3, 4, and 5, alkylation in the presence of mt SerRS at 1, 2, and 5 µM, respectively; lane 6, alkylation in the presence of human mt LeuRS (5 µM); lanes 7 and 8, partial ribonuclease T1, and U2 digests, respectively. The numbers to the right of the bands correspond to the base numbers for each tRNA. The phosphate positions protected against alkylation in the presence of mt SerRS are indicated by dashed lines. C, secondary structures of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (upper) and tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (lower); phosphate positions strongly protected by mt SerRS are indicated by arrowheads.

The crystal structure of T. thermophilus SerRS reveals that Arg195 contacts positions 66-67 in the acceptor helix of tRNASer, which is the same location as one of the mt SerRS contact sites. Because Arg195 is conserved in mammalian mt SerRS (18), it can be speculated that the contact site at phosphate positions 64-67 may not be required for specific recognition but would be involved in the essential interaction needed to arrange the CCA terminus at the catalytic center of the enzyme.

tRNA<UP><SUB><IT>UGA</IT></SUB><SUP><IT>Ser</IT></SUP></UP> Identity Elements for mt SerRS-- Although tRNA footprinting clearly demonstrated that mammalian mt SerRS contacts both isoacceptors similarly on the TPsi C loop and at the junction between the TPsi C and acceptor stems, it was still unclear how mt SerRS specifically recognizes two tRNAs having no common structure or sequence and identifies them among the 22 mt tRNAs. To clarify the unique recognition mechanism of mt SerRS, the identity elements of the respective isoacceptors needed to be determined.

To examine the recognition elements of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, we constructed several variants carrying a mutation(s), mainly at bases in the TPsi C loop, which is one of the mt SerRS contact sites and is predicted to be involved in tertiary interactions according to a previously proposed model (31). The mutational variations are shown in Fig. 4A, and the kinetic parameters are summarized in Table II. To achieve efficient transcription by T7 RNA polymerase, the two terminal base pairs, 1-72 and 2-71, were replaced with G·C pairs. The transcribed tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> with the canonical sequence was shown to have a Km value 4 times higher than that of the native tRNA from bovine liver. According to Hayashi et al. (32), replacement of the two terminal base pairs should have no effect on serylation activity, in which case the relatively high Km value is apparently attributable to the lack of modified bases.


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 4.   tRNA variants used in this study based on bovine mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (A), bovine mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (B), and chicken mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (C). The two terminal base pairs in the acceptor stems of bovine and chicken mt tRNAs<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, 1-72 and 2-71, were replaced with G·C pairs to achieve efficient in vitro transcription (see "Results"). To facilitate the expression of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> in E. coli cells, five A·U base pairs in the acceptor stem of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP>, 2-71, 3-70, 4-69, 5-68, and 6-67, were replaced with G·C pairs (see "Results"). Arrows indicate the substitutions, insertion, and deletions made in this study. Broken lines in A and B indicate the predicted tertiary base pairs proposed by Watanabe et al. (31) and de Bruijn et al. (36), respectively. The kinetic parameters for the tRNA variants of bovine/chicken mt tRNAs<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> and mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> are summarized in Tables II and III, respectively.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Kinetic parameters for bovine mitochondrial tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> transcripts

We first examined the variants with mutations in the anticodon at positions 34-36 and at the discriminator base (position 73), which are recognition elements in most tRNAs. Replacement of the anticodon sequence or the discriminator base caused no significant reduction in serylation activity. As it was revealed that the A73G mutation could be recognized more efficiently by the enzyme, mt SerRS apparently prefers G73 as the discriminator base, which is in agreement with a previous observation that a G73A mutation in tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> caused an ~3-fold reduction in activity (33). It can thus be postulated that tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> possesses the less efficient A73 as a discriminator base to balance the serine-accepting activities of the two isoacceptors in vivo (Table I).

Next, to evaluate the effects of tertiary interactions in mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> on serylation activity, point mutations were introduced at bases involved in four possible interactions (31): A15·U59, G18·U55, G19·C56, and U54·A58 (Fig. 4A). The A15·U59 interaction was shown not to be involved in the activity because the individual mutations A15U and U59A as well as the double mutation A15U,U59A all had relatively little effect in reducing the serylation activity (Table II). The variants G18U and U55G had kcat/Km values that were respectively reduced to 15 and 38% that of the wild type, which probably resulted from destabilization of D loop-TPsi C loop interaction induced by the mutations. Severely reduced serylation activity was induced by the mutations G19C and C56G, the relative kcat/Km values being 2 orders of magnitude lower (Table II). However, the variant carrying both mutations (G19C and C56G) completely recovered its activity, suggesting that the Watson-Crick base pair G19·C56 supporting D loop-TPsi C loop interaction is indispensable for recognition.

U54·A58 interaction in the TPsi C loop was also revealed to be a strong recognition element for serylation. The U54A and A58U mutants exhibited significantly reduced serylation activity. Unlike the case of the G19·C56 tertiary base pair, no restoration in the activity was observed in the double mutant U54A,A58U, indicating that mt SerRS probably recognizes the U54·A58 interaction not only structurally but also sequence-specifically in the TPsi C loop.

When compared with the canonical cloverleaf structure, mammalian mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> lacks six conserved residues, at positions 8, 16, 17, 21, 47, and 48, but contains one extra base pair (Psi 26a·A43a) in the anticodon stem so as to form a characteristic pseudo-cloverleaf structure (31). On the other hand, chicken mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> possesses the canonical cloverleaf structure (34). Further, it has already been demonstrated that the chicken tRNA can be serylated by the native bovine mt SerRS.2 To investigate the effect of the unusual cloverleaf structure of bovine mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> on its serylation activity, we designed a variant mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> possessing a canonical cloverleaf structure based on the chicken mt tRNASer sequence. All the residues of the chicken mt tRNASer apart from the D loop sequence were substituted for those of bovine mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (Fig. 4C). As this variant showed no significant change in serylation activity, it seems that the unusual cloverleaf structure of mammalian mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> does not function as a key element for discrimination by mammalian mt SerRS.

Tiranti et al. reported the presence of a heteroplasmic insertion at nucleotide position 7472 in human mt DNA (35). The insertion consequently adds one guanine at position 46.1 in the extra arm of human mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, and the authors suggest that this mutation etiologically induces deafness by altering the structure of the TPsi C loop in mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (35). In light of this, we constructed a variant based on bovine mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> containing the same mutation (Fig. 4A; G46.1 insertion) and examined its serylation activity. The mutation had little effect on the kcat/Km value, indicating that the deafness induced by the C7472 insertion is not caused by a defect in the serine-accepting activity.

From the foregoing, it is concluded that mammalian mt SerRS recognizes the mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> TPsi C loop sequence-specifically and requires the D loop-TPsi C loop interaction sustained by the G19·C56 tertiary base pair for efficient aminoacylation, whereas the characteristic pseudo-cloverleaf structure per se is hardly involved in the serylation reaction.

tRNA<UP><SUB><IT>GCU</IT></SUB><SUP><IT>Ser</IT></SUP></UP> Identity Elements for mt SerRS-- Ueda et al. (33) previously examined the recognition sites of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> using partially purified enzyme, but the activity was too weak for the kinetic parameters of several tRNA variants with low serine-accepting activity to be determined. Therefore, we investigated the identity elements for mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> using the recombinant enzyme with full activity. tRNA variants for mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> were prepared by the in vivo expression system developed by Hayashi et al. (25), which allows variants to be easily purified in large quantities. Five A·U base pairs in the acceptor stem were replaced with G·C pairs (Fig. 4B) for efficient expression as described (25). tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> expressed with the canonical sequence had a Km value 6 times higher than that of native tRNA (Table III). However, because Ueda et al. (33) previously revealed that the identity elements for mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> are not located in the acceptor stem, we prepared a series of tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> variants using the same expression system. The variations are shown in Fig. 4B, and the kinetic parameters are summarized in Table III. We first examined the serylation activity of the tRNA variant lacking a bulge (A43) in the anticodon stem, which is a conserved structure among mammalian mt tRNAs<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> and is considered to be involved in tertiary interaction with the TPsi C loop (16). This deletion hardly reduced the serylation activity. de Bruijn and Klug (36) proposed a tertiary structural model of human and bovine mt tRNAs<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> with four possible tertiary interactions, which are indicated by broken lines in Fig. 4B. Point mutations were introduced at the bases involved to evaluate the effects of these postulated tertiary interactions on serylation activity. The interactions U8·A60A, and A9·U59 were revealed to have no relation to the activity because the double mutation U8A,A9U did not substantially reduce serylation (Table III). On the other hand, the double mutation U59A,A60AU severely reduced the activity, indicating that mt SerRS recognizes U59 and A60A base-specifically. Similarly, the U10·A57 tertiary interaction was not involved in serylation because the U10A variant showed only a slight decrease in activity. To examine the U54·A58 interaction in the TPsi C loop, point mutations were introduced at positions 54 and 58. The U54A mutation reduced the kcat/Km value by four-fifths, but this was relatively little compared with the drastic loss of activity by 2 orders of magnitude in the A58U variant (Table III). Because no activity was restored by introducing the double mutation U54A,A58U, which actually resulted in an even more severe decrease in the kcat/Km value, it can be assumed that the mt SerRS recognizes A58 base-specifically. With regard to the individual effects of the two point mutations on serylation activity, the theoretical activity derived by multiplying the kcat/Km values of the respective mutations should be in good agreement with the observed value. Because the theoretical value for the double mutation (0.0039) did in fact correspond well with the experimental value (0.0059), U54A and A58U were shown to be mutations that individually reduced the serylation activity. Finally, a point mutation was introduced at position 57, which is one of the strong footprint sites; this A57U mutation markedly reduced the activity.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Kinetic parameters for bovine mitochondrial tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> derivatives expressed in E. coli

From the foregoing, it can be concluded that mammalian mt SerRS recognizes the TPsi C loop sequence of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> but, unlike the case of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> recognition, it does not recognize its tertiary structure. The major determinants, A57 and A58, were shown to be the sites footprinted by the enzyme (Fig. 3A).

Dual Mode Recognition of the Two Isoacceptors by mt SerRS-- Our findings on the identity elements of the two structurally dissimilar isoaccepting tRNAs raised the possibility that mammalian mt SerRS recognizes each tRNA by two distinct mechanisms. To examine this notion, we constructed mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> variants in which the D arm and/or TPsi C loop were substituted by the D arm and TPsi C loop configurations of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (Fig. 4A). As shown in Table II, the variant with the D arm substitution (i.e. lacking a D arm, as is the case in mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP>) had a seriously decreased kcat/Km value, whereas the activity was increased 3-fold by substituting the TPsi C loop. The third variant, carrying both the D arm and TPsi C loop substitutions, showed similar serylation activity to that of the canonical transcript. These findings clearly indicated that the D loop-TPsi C loop tertiary interactions are required for the serylation of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, whereas only the sequence of the TPsi C loop is important for the activity of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP>.

Aminoacylation of E. coli tRNAAla by alanyl-tRNA synthetase (AlaRS) depends on a G3·U70 wobble base pair in the acceptor stem (37). Understanding such a unique identity determinant was greatly advanced by the demonstration that the minihelix variant, composed only of the amino acid acceptor-TPsi C helix, could be a good substrate for AlaRS (38, 39). Therefore, to confirm the dual mode recognition of the two tRNASer species, we similarly prepared two minihelix tRNAsSer based on the two isoacceptor tRNAs by connecting the acceptor stem and the TPsi C stem (Fig. 5A). As expected, the tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> minihelix exhibited significant serylation activity (Fig. 5B, and Table III), whereas the tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> minihelix showed none (Fig. 5B, and Table II).


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 5.   Secondary structures of minihelix tRNAsSer and their serylation activities. A, secondary structures of minihelices derived from the acceptor/TPsi C helices of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> and mt tRNAs<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, respectively. B, serine accepting activities of minihelices derived from tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (black-triangle) and tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (), and serylation of mt tRNAs<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (black-square) plotted as a positive control. The kinetic parameters are shown in Tables II and III. The experimental conditions are described under "Experimental Procedures."

The above results clearly demonstrated that mammalian mt SerRS recognizes the TPsi C loop of tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> well in a sequence-specific manner. At the same time, the necessity of dissimilar tertiary interactions for the recognition of the two mt tRNAsSer by mt SerRS was underscored by this experiment. Thus, there are both common and dissimilar features in the recognition mechanisms of the single enzyme for the two substrates.

Misacylation of mt tRNAGln by mt SerRS-- Because the TPsi C loop sequence of each serine tRNA was shown to be important for serylation, we searched mt tRNA sequences to discover whether a TPsi C loop sequence similar to that of either of the two serine tRNAs exists among the 20 non-cognate mt tRNAs. Although no other bovine mt tRNA has a sequence resembling the TPsi C loop of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> (40), three bovine mt tRNAs (for Gln, Glu, and Tyr) have TPsi C loop sequences the same as or similar to that of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>; the mt tRNAGln sequence is identical, that of mt tRNAGlu shows one nucleotide change (C56A), and tRNATyr has two changes (C56U/U59C). Therefore, using native mt tRNAs from bovine liver, we examined the mt SerRS misacylation activity for each of these tRNAs. The results are shown in Fig. 6 and Table IV. No activity was observed for the two tRNAs with TPsi C loop sequences similar to that of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (mt tRNAGlu and mt tRNATyr).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   Misacylation of non-cognate bovine mt tRNAGln by mt SerRS. The serine-accepting activities of mt tRNAs<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (black-triangle), mt tRNAGln (), mt tRNAGlu (×), and mt tRNATyr () were determined under the same experimental conditions as those used for the plots in Fig. 5B. The kinetic parameters are shown in Table IV.

                              
View this table:
[in this window]
[in a new window]
 
Table IV
Kinetic parameters for several bovine mitochondrial tRNAs and in vitro transcripts
#, nucleotides in the TPsi C loop differing from those of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> at the same position are shown by outlined letters. *, n.d., no activity was detected.

To check the negative effects of these small changes in the TPsi C loop sequence on serylation activity, we constructed two tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> variants, C56A and C56U,U59C, with TPsi C loop sequences respectively corresponding to those of mt tRNAGlu and mt tRNATyr (Fig. 4A). These mutants showed 60-fold or more reductions in their kcat/Km values (Table II), indicating that the variant TPsi C loop nucleotides in the mt tRNAs for Glu and Tyr function as strong negative determinants in preventing misacylation by mt SerRS, thereby maintaining the fidelity of translation, i.e. mt SerRS seems to reject these non-cognate mt tRNAs on the basis of their TPsi C loop sequences. mt tRNAGln, whose TPsi C loop sequence is identical to that of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, was found to be misacylated slightly but significantly by mt SerRS (Fig. 6), although its kcat/Km value was 4 orders of magnitude smaller compared with that of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> (Table IV). This finding is a novel instance that appears to exist in the aminoacylation network to maintain a high level of translational fidelity. Further experiments were carried out to elucidate this notion.

Discrimination of mt tRNA<UP><SUB><IT>UGA</IT></SUB><SUP><IT>Ser</IT></SUP></UP> from Non-cognate mt tRNAGln by mt SerRS-- As noted above, although mt tRNAGln can be misacylated by mt SerRS, the activity is kept at a low level even though mt tRNAGln possesses the same TPsi C loop sequence as mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>. To exclude the possible influence of modified nucleotides, unmodified mt tRNAGln was prepared by in vitro transcription. The data in Table IV show that this mt tRNAGln transcript still had serylation activity 10-fold higher than that of the native tRNA. The misacylation activity of the unmodified mt tRNAGln decreased ~42-fold when compared with the activity of unmodified mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>.

We next investigated the sequence elements embedded in mt tRNAGln to reduce misacylation by mt SerRS. We focused on the G·U base pairs in the TPsi C stems of mt tRNAGln and mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, of which the former has one and the latter has two. It has been reported that a G·U base pair in an RNA duplex distorts the conformation of the phosphodiester backbone (41). We therefore postulated that the number and/or location of the wobble base pairs in the TPsi C stem may have an effect on the recognition of the TPsi C loop by mt SerRS. To investigate this possibility, several tRNAs<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> variants with mutations in their TPsi C stems were constructed by altering the number and/or location of the G·U base pairs. As shown in Table V, substituting either or both of the mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> G·U base pairs with G·C (v1, v2, and v3) had no significant effect on serylation. However, the variant with a single G·U base pair at the same position as that in mt tRNAGln (v4) showed a 15-fold reduction in serylation activity. This result suggests that a single base pair, G49·U64, in TPsi C stem of mt tRNAGln acts as one of the negative determinants for serylation by mt SerRS.

                              
View this table:
[in this window]
[in a new window]
 
Table V
Kinetic parameters for tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> transcripts possessing mutations in the TPsi C stem
#, nucleotides in the TPsi C stem differing from those of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> at the same position are shown by outlined letters.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

In general, isoacceptor tRNAs possess common sequences or structures as identity elements for recognition by a cognate aminoacyl-tRNA synthetase and to exclude recognition by non-cognate synthetases. Thus, determining common features of isoacceptors provides an important clue for predicting possible identity elements. In fact, a number of identity elements of various tRNAs so far studied correspond well to common sequences or structures, particularly the anticodon sequence, discriminator base, and acceptor stem (15). However, in the case of mammalian mitochondrial serine tRNAs, it is difficult to extract common features of the two isoacceptors, mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> and mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>. In addition to there being no apparent consensus sequence between these two tRNAs, structurally each has a distinct topology. One speculation had been that two species of SerRS might exist, one for each tRNA, as in the case of two threonyl-tRNA synthetases in yeast mitochondria (42). However, we demonstrated recently (18) that a single enzyme specifically recognizes the two isoacceptors. How, then, does this mt SerRS recognize and discriminate these two dissimilar tRNAs from non-cognate species?

The footprinting experiment with the mt SerRS-mt tRNASer complex revealed that the enzyme contacts both tRNAs at nearly the same position; the TPsi C loop and the bottom of the acceptor stem (Fig. 3). The series of mutation studies clearly demonstrated that one of the contact sites, the TPsi C loop sequence, is important for recognition in both cases. Herein can be found commonality in the recognition of the two dissimilar tRNAs by mt SerRS. However, we next noted that mt SerRS recognizes the TPsi C loop in each tRNA by distinctive mechanisms, because TPsi C loop-D loop tertiary interaction is required for the recognition of only mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>. The different modes of recognition for the two substrates was accentuated by the fact that the minihelix variant of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP> was a good substrate for mt SerRS, whereas that of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> was not (Fig. 5).

Crystallographic studies have revealed that E. coli SerRS has a long helical arm consisting of an antiparallel, two-stranded coiled coil in the N-terminal domain (27, 28). In the crystal structure of T. thermophilus SerRS complexed with tRNASer, the N-terminal helical arm is tightly buried in the gulf between the TPsi C arm and the long extra arm of tRNASer with several backbone contacts, whereas the C-terminal region of another subunit is responsible for the catalytic activity (9). However, during the process of mitochondrial evolution in the eukaryotic cell, prokaryotic tRNAsSer would have lost their characteristic extra arms, whereas the D arm was lost only in the case of mt tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP>. Accordingly, the N-terminal region of mt SerRS might have been obliged to recognize the TPsi C loop of mt tRNASer instead of the missing extra arm, because the catalytic core in the C-terminal region is well conserved in mt SerRS (18). Despite low homology in the N-terminal domain between mt SerRS and prokaryotic enzymes, a single, long helical arm was clearly predicted in the N-terminal region of bovine mt SerRS both by the CD spectrum of the recombinant enzyme and computational analysis of the helical structure using the COILS algorithm. It can be speculated that the predicted N-terminal helical arm of mt SerRS may also be responsible for mt tRNA recognition through interaction with the TPsi C loop. However, an investigation of the tertiary structure of the mt SerRS-mt tRNASer complex is required to elucidate how the N-terminal arm recognizes the TPsi C loop of each tRNA. The molecular basis of the precise mechanism of the dual mode recognition will be clarified by such a structural study, which is now in progress in our laboratory.

The error rate of translation has been estimated to be 10-4 to 10-5 (43), which is of the same order as misacylation (44), indicating that the fidelity of translation was maintained by the accuracy of aminoacylation. In Candida species, the codon CUG is known to be translated as serine instead of leucine by the tRNA<UP><SUB>CAG</SUB><SUP>Ser</SUP></UP> responsible for this non-universal decoding (45, 46). We previously reported that this tRNA<UP><SUB>CAG</SUB><SUP>Ser</SUP></UP> can be aminoacylated not only with serine, but also with leucine to some extent in vitro as well as in vivo (47). This was the first report, and a unique instance, of a single tRNA in a natural organism being acceptable to more than one species of amino acid. In the present study, we unexpectedly found that mt tRNAGln can be slightly but significantly misacylated by mt SerRS (Table IV and Fig. 6), because mt tRNAGln has a TPsi C loop sequence identical to that of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>. Although ambiguous specificity of mt aminoacyl-tRNA synthetase has been reported in unilateral aminoacylation between heterologous tRNAs (48), it was a surprise that mt SerRS cannot discriminate a cognate tRNA strictly even inside the mitochondrion. The fact that the recognition of mt tRNAGln by mt SerRS in vitro is 3700 times lower than that of mt tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP> suggests that kinetic discrimination arising from competition between mt SerRS and mt GlnRS occurs in the mitochondrion to maintain the fidelity of mt translation. It can be speculated that a reduction in the number of tRNA species might impair the discriminatory ability of mt ARS. Our finding raises the possibility that other mammalian mt aminoacyl-tRNA synthetases may also misacylate non-cognate mt tRNAs, with the fidelity of mt translation being maintained by the kinetic discrimination of mt tRNAs in the network of ARSs. Further studies will certainly clarify this notion and, as a result, deepen our understanding of the mammalian mitochondrial translation system.

    ACKNOWLEDGEMENTS

We are grateful to Dr. Linda L. Spremulli (University of North Carolina, Chapel Hill, NC) for providing the expression vector of human mt LeuRS. We thank Drs. Takashi Yokogawa (Gifu University, Gifu, Japan), Hyota Himeno (Hirosaki University, Aomori, Japan), Akiko Soma (RIKEN, Japan), and Takashi Ohtsuki (University of Tokyo, Tokyo, Japan) for helpful discussions and our colleagues Takehiro Yasukawa, Takeo Suzuki, Yukihide Tomari, and Yoshihiro Shimizu (University of Tokyo, Tokyo, Japan) for gifts of human mt LeuRS, bovine mt tRNAs, E. coli CCA-adding enzyme, and E. coli SerRS, respectively.

    FOOTNOTES

* This work was supported by a grant-in-aid for scientific research on priority areas from the Ministry of Education, Culture, Sports, Science and Technology (Japan).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed. Tel.: 81-471-36-3601; Fax: 81-471-36-3600; E-mail: kw@kwl.t.u-tokyo.ac.jp.

Published, JBC Papers in Press, September 27, 2001, DOI 10.1074/jbc.M105150200

2 N. Nishioka, T. Yokogawa, and K. Watanabe, unpublished data.

    ABBREVIATIONS

The abbreviations used are: ARS, aminoacyl-tRNA synthetase; SerRS, seryl-tRNA synthetase; mt, mitochondrial; tRNA<UP><SUB>GCU</SUB><SUP>Ser</SUP></UP>, serine-specific tRNA having the anticodon GCU corresponding to the codon AGY; tRNA<UP><SUB>UGA</SUB><SUP>Ser</SUP></UP>, serine-specific tRNA having the anticodon UGA corresponding to the codon UCN; tRNA<UP><SUB>UAA</SUB><SUP>Leu</SUP></UP>, leucine-specific tRNA having the anticodon UAA corresponding to the codon UUR; AlaRS, alanyl-tRNA synthetase; mt LeuRS, mt leucyl-tRNA synthetase; tRNAGln, glutamine-specific tRNA; tRNAGlu, glutamic acid-specific tRNA; tRNATyr, tyrosine-specific tRNA; PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Normanly, J., and Abelson, J. (1989) Annu. Rev. Biochem. 58, 1029-1049[CrossRef][Medline] [Order article via Infotrieve]
2. Schulman, L. H. (1991) Prog. Nucleic Acids Res. Mol. Biol. 41, 23-87[Medline] [Order article via Infotrieve]
3. Shimizu, M., Asahara, H., Tamura, K., Hasegawa, T., and Himeno, H. (1992) J. Mol. Evol. 35, 436-443[Medline] [Order article via Infotrieve]
4. Himeno, H., Hasegawa, T., Ueda, T., Watanabe, K., and Shimizu, M. (1990) Nucleic Acids Res. 18, 6815-6819[Abstract/Free Full Text]
5. Sampson, J. R., and Saks, M. E. (1993) Nucleic Acids Res. 21, 4467-4475[Abstract/Free Full Text]
6. Schatz, D., Leberman, R., and Eckstein, F. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 6132-6136[Abstract/Free Full Text]
7. Asahara, H., Himeno, H., Tamura, K., Nameki, N., Hasegawa, T., and Shimizu, M. (1994) J. Mol. Biol. 236, 738-748[CrossRef][Medline] [Order article via Infotrieve]
8. Price, S., Cusack, S., Borel, F., Berthet-Colominas, C., and Leberman, R. (1993) FEBS Lett. 324, 167-170[CrossRef][Medline] [Order article via Infotrieve]
9. Biou, V., Yaremchuk, A., Tukalo, M., and Cusack, S. (1994) Science 263, 1404-1410[Abstract/Free Full Text]
10. Cusack, S., Yaremchuk, A., and Tukalo, M. (1996) EMBO J. 15, 2834-2842[Medline] [Order article via Infotrieve]
11. Achsel, T., and Gross, H. J. (1993) EMBO J. 12, 3333-3338[Medline] [Order article via Infotrieve]
12. Dock-Bregeon, A. C., Garcia, A., Giege, R., and Moras, D. (1990) Eur. J. Biochem. 188, 283-290[Medline] [Order article via Infotrieve]
13. Wu, X.-Q., and Gross, H. J. (1993) Nucleic Acids Res. 21, 5589-5594[Abstract/Free Full Text]
14. Himeno, H., Yoshida, S., Soma, A., and Nishikawa, K. (1997) J. Mol. Biol. 268, 704-711[CrossRef][Medline] [Order article via Infotrieve]
15. Lenhard, B., Orellana, O., Ibba, M., and Weygand-Durasevic, I. (1999) Nucleic Acids Res. 27, 721-729[Abstract/Free Full Text]
16. Steinberg, S., Gautheret, D., and Cedergren, R. (1994) J. Mol. Biol. 236, 982-989[CrossRef][Medline] [Order article via Infotrieve]
17. Yokogawa, T., Watanabe, Y., Kumazawa, Y., Ueda, T., Hirao, I., Miura, K., and Watanabe, K. (1991) Nucleic Acids Res. 19, 6101-6105[Abstract/Free Full Text]
18. Yokogawa, T., Shimada, N., Takeuchi, N., Benkowski, L., Suzuki, T., Omori, A., Ueda, T., Nishikawa, K., Spremulli, L. L., and Watanabe, K. (2000) J. Biol. Chem. 275, 19913-19920[Abstract/Free Full Text]
19. Wakita, K., Watanabe, Y., Yokogawa, T., Kumazawa, Y., Nakamura, S., Ueda, T., Watanabe, K., and Nishikawa, K. (1994) Nucleic Acids Res. 22, 347-353[Abstract/Free Full Text]
20. Hornung, V., Hofmann, H. P., and Sprinzl, M. (1998) Biochemistry 37, 7260-7267[CrossRef][Medline] [Order article via Infotrieve]
21. Vlassov, V. V., Kern, D., Giege, R., and Ebel, J. P. (1981) FEBS Lett. 123, 277-281[CrossRef][Medline] [Order article via Infotrieve]
22. Reyes, V. M., and Abelson, J. (1987) Anal. Biochem. 166, 90-106[CrossRef][Medline] [Order article via Infotrieve]
23. Sampson, J. R., and Uhlenbeck, O. C. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 1033-1037[Abstract/Free Full Text]
24. Donis-Keller, H. (1980) Nucleic Acids Res. 8, 3133-3142[Abstract/Free Full Text]
25. Hayashi, I., Kawai, G., and Watanabe, K. (1997) Nucleic Acids Res. 25, 3503-3507[Abstract/Free Full Text]
26. Chomczynski, P., and Sacchi, N. (1987) Anal. Biochem. 162, 156-159[Medline] [Order article via Infotrieve]
27. Oakley, M. G., and Kim, P. S. (1997) Biochemistry 36, 2544-2549[CrossRef][Medline] [Order article via Infotrieve]
28. Cusack, S., Berthet-Colominas, C., Hartlein, M., Nassar, N., and Leberman, R. (1990) Nature 347, 249-255[CrossRef][Medline] [Order article via Infotrieve]
29. Lupas, A., Van Dyke, M., and Stock, J. (1991) Science 252, 1162-1164[Free Full Text]
30. Belrhali, H., Yaremchuk, A., Tukalo, M., Larsen, K., Berthet-Colominas, C., Leberman, R., Beijer, B., Sproat, B., Als-Nielsen, J., Grubel, G., Legrand, J.-F., Lehmann, M., and Cusack, S. (1994) Science 263, 1432-1436[Abstract/Free Full Text]
31. Watanabe, Y., Kawai, G., Yokogawa, T., Hayashi, N., Kumazawa, Y., Ueda, T., Nishikawa, K., Hirao, I., Miura, K., and Watanabe, K. (1994) Nucleic Acids Res. 22, 5378-5384[Abstract/Free Full Text]
32. Hayashi, I., Kawai, G., and Watanabe, K. (1998) J. Mol. Biol. 284, 57-69[CrossRef][Medline] [Order article via Infotrieve]
33. Ueda, T., Yotsumoto, Y., Ikeda, K., and Watanabe, K. (1992) Nucleic Acids Res. 20, 2217-2222[Abstract/Free Full Text]
34. Nishioka, N., Yokogawa, T., Ueda, T., Watanabe, K., and Nishikawa, K. (1994) Nucleic Acids Symp. Ser. 31, 187-188
35. Tiranti, V., Chariot, P., Carella, F., Toscano, A., Soliveri, P., Girlanda, P., Carrara, F., Fratta, G. M., Reid, F. M., Mariotti, C., and Zeviani, M. (1995) Hum. Mol. Genet. 4, 1421-1427[Abstract/Free Full Text]
36. de Bruijn, M. H., and Klug, A. (1983) EMBO J. 2, 1309-1321[Medline] [Order article via Infotrieve]
37. Chang, K. Y., Varani, G., Bhattacharya, S., Choi, H., and McClain, W. H. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 11764-11769[Abstract/Free Full Text]
38. Francklyn, C., and Schimmel, P. (1989) Nature 337, 478-481[CrossRef][Medline] [Order article via Infotrieve]
39. McClain, W. H., and Foss, K. (1988) Science 240, 793-796[Abstract/Free Full Text]
40. Sprinzl, M., Horn, C., Brown, M., Ioudovitch, A., and Steinberg, S. (1998) Nucleic Acids Res. 26, 148-153[Abstract/Free Full Text]
41. Ramos, A., and Varani, G. (1997) Nucleic Acids Res. 25, 2083-2090[Abstract/Free Full Text]
42. Pape, L. K., Koerner, T. J., and Tzagoloff, A. (1985) J. Biol. Chem. 260, 15362-15370[Abstract/Free Full Text]
43. Loftfield, R. B., and Vanderjagt, D. (1972) Biochem. J. 128, 1353-1356[Medline] [Order article via Infotrieve]
44. Parker, J. (1989) Microbiol. Rev. 53, 273-298[Free Full Text]
45. Kawaguchi, Y., Honda, H., Taniguchi-Morimura, J., and Iwasaki, S. (1989) Nature 341, 164-166[CrossRef][Medline] [Order article via Infotrieve]
46. Ohama, T., Suzuki, T., Mori, M., Osawa, S., Ueda, T., Watanabe, K., and Nakase, T. (1993) Nucleic Acids Res. 21, 4039-4045[Abstract/Free Full Text]
47. Suzuki, T., Ueda, T., and Watanabe, K. (1997) EMBO J. 16, 1122-1134[CrossRef][Medline] [Order article via Infotrieve]
48. Kumazawa, Y., Himeno, H., Miura, K., and Watanabe, K. (1991) J. Biochem. (Tokyo) 109, 421-427[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
S. Bilokapic, N. Ivic, V. Godinic-Mikulcic, I. Piantanida, N. Ban, and I. Weygand-Durasevic
Idiosyncratic Helix-Turn-Helix Motif in Methanosarcina barkeri Seryl-tRNA Synthetase Has a Critical Architectural Role
J. Biol. Chem., April 17, 2009; 284(16): 10706 - 10713.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Arita, T. Suematsu, A. Osanai, T. Inaba, H. Kamiya, K. Kita, M. Sisido, Y.-i. Watanabe, and T. Ohtsuki
An evolutionary 'intermediate state' of mitochondrial translation systems found in Trichinella species of parasitic nematodes: co-evolution of tRNA and EF-Tu
Nucleic Acids Res., October 6, 2006; 34(18): 5291 - 5299.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
M. Mollers, K. Maniura-Weber, E. Kiseljakovic, M. Bust, A. Hayrapetyan, M. Jaksch, M. Helm, R. J. Wiesner, and J.-C. von Kleist-Retzow
A new mechanism for mtDNA pathogenesis: impairment of post-transcriptional maturation leads to severe depletion of mitochondrial tRNASer(UCN) caused by T7512C and G7497A point mutations
Nucleic Acids Res., September 30, 2005; 33(17): 5647 - 5658.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
T. Suematsu, A. Sato, M. Sakurai, K. Watanabe, and T. Ohtsuki
A unique tRNA recognition mechanism of Caenorhabditis elegans mitochondrial EF-Tu2
Nucleic Acids Res., August 19, 2005; 33(15): 4683 - 4691.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. Korencic, C. Polycarpo, I. Weygand-Durasevic, and D. Soll
Differential Modes of Transfer RNASer Recognition in Methanosarcina barkeri
J. Biol. Chem., November 19, 2004; 279(47): 48780 - 48786.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
L. Levinger, M. Morl, and C. Florentz
Mitochondrial tRNA 3' end metabolism and human disease
Nucleic Acids Res., October 11, 2004; 32(18): 5430 - 5441.
[Abstract] [Full Text] [PDF]


Home page
RNAHome page
M. SISSLER, M. HELM, M. FRUGIER, R. GIEGE, and C. FLORENTZ
Aminoacylation properties of pathology-related human mitochondrial tRNALys variants
RNA, May 1, 2004; 10(5): 841 - 853.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. A. Rawlings, T. M. Collins, and R. Bieler
Changing identities: tRNA duplication and remolding within animal mitochondrial genomes
PNAS, December 23, 2003; 100(26): 15700 - 15705.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Toompuu, T. Yasukawa, T. Suzuki, T. Hakkinen, J. N. Spelbrink, K. Watanabe, and H. T. Jacobs
The 7472insC Mitochondrial DNA Mutation Impairs the Synthesis and Extent of Aminoacylation of tRNASer(UCN) but Not Its Structure or Rate of Turnover
J. Biol. Chem., June 14, 2002; 277(25): 22240 - 22250.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/50/46770    most recent
M105150200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimada, N.
Right arrow Articles by Watanabe, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimada, N.
Right arrow Articles by Watanabe, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement